Equity
-€6,839
Debts exceed assets in financial year 2025.
CORE THERAPY
Lifetime
1 annual account with figurespeak -€6,732 (2025)
-€6,732
lowest -€7,339 (2025)
-€7,339
peak -€6,839 (2025)
-€6,839
€128,730
Board1 name since 2025
1 directorLaurent Jean Jacques PESTIAUX
Documentsfilings and deeds
28-08-202628 days late
2025micro format
Loss of €7,339Incorporation 14-101 establishment registeredFirst year with figures
Key points
from the 2025 annual accountsDebts
€128,730 106% of the balance sheet
Financial debts 80%Suppliers 0%Other 20%
Of this, €25,753 falls due within a year.
Position in the sector
-5.6%
Lower solvency than 84% of companies in real estate. Sector median 28.9% · 17,194 companies.
2025 accounts filed 28 days after the deadlineTurnover not published (micro format)
Checked score
55
Fair
Financially stronger than 40% of micro companies in real estate (NACE 68)
Probability in this band: 1.5% to 4.2%
Negative equity caps the score at 59.
Bankruptcy probability within 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.2% across 26,627 companies (NACE 68, micro).
About 4 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Financial strengthWeak
Score breakdown
raises risk
Capped at 59: negative equity
Negative equity -€6,839
lowers risk
Sector: Real estate activities (NACE 68)
Liquidity: current ratio 2.48, cash €32,401
Size: total assets €121,891
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 68, micro). It does better than 15% of them on solvency, 84% on liquidity and 22% on profitability.
The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 232 companies had the same profile as CORE THERAPY has now. Each dot is one company, two years later.
96.1%
were still trading
2.2%
stopped another way
1.7%
went bankrupt
That fits the bankruptcy probability of CORE THERAPY itself: 0.4% within 12 months.
Test of the method
The method was tested on the 497,448 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 232 companies, not a prediction for CORE THERAPY. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
No credit on open account
Liquidity is ample, with a current ratio of 2.48, above the usual 1.5. Short-term debt is 21.1% and cash 26.6% of total assets. However, equity is negative.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Seven signals.
lowers riskraises risk
raises risk · Young company
Founded in 2025, a year ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation dateAge against the risk zone
raises risk · 2025 accounts filed 28 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-08-2026, 28 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 1 filingDeviation from the deadline
2025
28 days late
← before the deadline
after the deadline →
Searched, nothing found (1)
Board and ownership
- PESTIAUX Laurent Jean Jacques founderdeed of 14-10-2025
- Laurent Pestiaux 500 sharesdeed of 14-10-2025
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1028990945
Incorporation
Founding capital of €500, 500 shares · Founder: PESTIAUX Laurent Jean Jacques · Appointment: PESTIAUX Laurent Jean Jacques (director) · published on 14-10-2025 · Gazette deed
First establishment
Route de Genval 16, Lasne
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| CORE THERAPY Lasne | €121,891 | -€6,732 | -5.6% | - |
| SUMAJA Scherpenheuvel-Zichem | €135,362 | -€450 | 6.1% | - |
| GEMEENTEHUIS Ghent | €111,008 | -€9,733 | 27.3% | - |
| Atout Brique Nivelles | €104,952 | -€38,231 | -10.1% | - |
| Axihome Anthisnes | €160,016 | -€6,433 | 0.1% | - |
| DVCoeurSanté Woluwe-Saint-Pierre | €98,771 | -€18,360 | -20.8% | - |
| CELLE & CO. Hamont-Achel | €88,829 | -€4,028 | 96.3% | - |
These companies have the same main activity as CORE THERAPY: renting and operating of own or leased non-residential real estate, excluding land (NACE 68203). They are comparable in size and age: total assets between €88,800 and €160,000, founded in 2025.
Official details
Source: KBO- Status
- Active since 10-10-2025Normal situation
- Registered office
- 13 active companies are registered at this address1 started in the 12 months before. Source: KBO register, as of 10 November 2026.
- Activity
- Renting and operating of own or leased non-residential real estate, excluding landNACE 68203
- Establishment unit
- 2.379.883.8151380 Lasne, since 10-10-2025
- Financial year end
- 31 December
- Peppol
- Reachable since 03-12-2025
Insights on CORE THERAPY
CORE THERAPY has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€6,839) and a net result of -€7,339.
Its solvency ranks better than 15% of 17,194 sector peers (NACE 68, financial year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about CORE THERAPY
- What is the company number of CORE THERAPY?
- The company number of CORE THERAPY is 1028.990.945. The VAT number is the same number with BE in front: BE 1028.990.945.
- Where is CORE THERAPY based?
- The registered office is at Route de Genval 16, 1380 Lasne.Company details
- What does CORE THERAPY do?
- According to the KBO register, the main activity is renting and operating of own or leased non-residential real estate, excluding land (NACE 68203).
- What is the legal form of CORE THERAPY?
- CORE THERAPY is a private limited company (BV).
- When was CORE THERAPY founded?
- CORE THERAPY was founded on 10-10-2025.
- Is CORE THERAPY still active?
- Yes, CORE THERAPY is an active enterprise in the KBO register.
- What is the turnover of CORE THERAPY?
- The annual accounts for financial year 2025 state no turnover. The micro format does not require it.Financials
- Is CORE THERAPY profitable?
- In financial year 2025, CORE THERAPY made a loss of €7,339.
- Where can I find the annual accounts of CORE THERAPY?
- CORE THERAPY filed 1 annual account with the National Bank of Belgium, for financial year 2025.
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark Estimate what this company is worth.Value indication
See how customers, suppliers and banks see your own company and what to improve first.